Tech Company Financing Transactions
Neuroptix Funding Round
On 1/18/2007, Neuroptix raised $1.6 million in Series A funding from Launchpad Venture Group and Maine Angels.
Transaction Overview
Company Name
Announced On
1/18/2007
Transaction Type
Venture Equity
Amount
$1,600,000
Round
Series A
Investors
Launchpad Venture Group (Lead Investor)
Proceeds Purpose
Paul Hartung, President and CEO of Neuroptix, said, "The Neuroptix team is delighted with the outcome of our Series A funding round, which brings us closer to achieving our goal of commercializing an upcoming predictive, reliable, inexpensive and widely available test that can be performed quickly and accurately by a general practitioner in an office setting, to enable swift intervention and ongoing monitoring of patients."
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
20 Main St.
Acton, MA 01720
USA
Acton, MA 01720
USA
Phone
Website
Email Address
Overview
Neuroptix develops, manufactures and distributes state-of-the-art products for extremely sensitive measurements of biophysical changes in the eye, including non-invasive instruments for diagnosis and monitoring Alzheimer's disease undergoing clinical development.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Paul Hartung
Chief Financial Officer
Tom Trometer
VP - Marketing
Anne Cameron
Browse more venture capital transactions:
Prev: 1/18/2007: Workshare venture capital transaction
Next: 1/19/2007: InovaWave venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on funding rounds that are announced publicly. VC investment data records reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs